Skip to main content
. 2020 Jul 28;10(3):915–925. doi: 10.3233/JPD-202010

Fig. 1.

Fig. 1

Study Schematic. CD-LD ER, carbidopa-levodopa extended release; CD-LD IR, carbidopa-levodopa immediate release; DB, double-blind; OL, open label.